Background

The immunohistochemistry (IHC) division at MPLN utilizes advanced diagnostic techniques to evaluate protein expression of cells within tissues. IHC assists in identifying the distribution and localization of biomarkers, aiding in diagnosis and targeted therapy selection. IHC utilizes enzyme-based reactions in conjunction with mono- or polyclonal antibodies to evaluate protein expression levels and locate sub cellular antigens in tissues.

Resources

PD-L1 (Ventana SP263) now available
Immunohistochemistry Test Menu

Immunohistochemistry Tests

Abc-Z Immunohistochemistry Antibodies (IHC)

B-cell Lymphoma Markers by Immunohistochemistry (IHC)

Bone Marrow Progenitors/Leukemia/Blastic Markers by Immunohistochemistry (IHC)

Breast Markers by Immunohistochemistry (IHC)

Carcinoma / Mesothelial Markers by Immunohostochemistry (IHC)

Chromogenic In-Situ Hybridization (CISH) Probes

CNS Markers by Immunohostochemistry (IHC)

Head and Neck Immunohistochemistry markers

Hodgkin / Anaplastic Lymphoma Markers by Immunohistochemistry (IHC)

Immunohistochemistry (IHC) A-Z menu

Infectious Disease Markers by Immunohistochemistry (IHC)

Keratin/Epithelial Markers by Immunohistochemistry (IHC)

Lung Markers by Immunohistochemistry (IHC)

Melanocytic Markers by Immunohistochemistry (IHC)

Microsatellite Instability Marker Profile by Immunohistochemistry (IHC)

Myoepithelial, Basal, Basement Membrane Markers by Immunohistochemistry (IHC)

Neuroendocrine Markers/Other Hormones by Immunohistochemistry (IHC)

Panhematopoetic Markers by Immunohistochemistry (IHC)

PD-1 by IHC

PD-L1 by IHC

← prev 1 2 next →